Regulation of nuclear membrane assembly and maintenance during in vitro maturation of mouse oocytes: role of pyruvate and protein synthesis.
In the absence of a suitable energy source, mouse oocytes cultured in vitro resume, but fail to complete, meiotic maturation. However, little is known about the underlying mechanisms leading to this meiotic failure. We utilized pyruvate-deficient medium to test for the role of pyruvate throughout the meiotic maturation process. Germinal vesicle-stage (GV) oocytes underwent germinal vesicle breakdown (GVBD), but failed to form a polar body when cultured continuously in pyruvate-free medium. However, when GV oocytes were preincubated for 4 h in pyruvate-free medium containing dibutyryl cyclic adenosine monophosphate (dbcAMP) and then cultured in pyruvate-free medium, GVBD was markedly inhibited. Preincubation of GV oocytes in dbcAMP and cycloheximide, followed by culture in cycloheximide only, also inhibited GVBD. A longer preincubation period was required in the cycloheximide-dbcAMP case (12 h) than in pyruvate-free-dbcAMP medium situation (4 h). Strikingly, reassembly of the nuclear membrane without polar body formation was observed following GVBD in oocytes continuously cultured in pyruvate-free medium. The reassembled nuclear membrane increased in size with continued culture, and it surrounded partially-decondensed chromatin. Nuclear membrane reassembly also occurred in oocytes which had undergone GVBD during continuous culture in medium containing only cycloheximide. Reformation of nuclear membranes after GVBD was confirmed by electron-microscopic analyses of oocytes cultured in pyruvate-free medium or in the presence of cycloheximide.(ABSTRACT TRUNCATED AT 250 WORDS)
Kim
H
H
Department of Population Dynamics, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MD 21205.
Schuetz
A W
AW
D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D005260:Female; D007425:Intracellular Membranes / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D051379:Mice; D008813:Mice, Inbred ICR; D008854:Microscopy, Electron; D009865:Oocytes / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D009866:Oogenesis / Q000187:drug effects; D014176:Protein Biosynthesis; D011773:Pyruvates / Q000494:pharmacology*
D011773:Pyruvates; D003513:Cycloheximide; D000242:Cyclic AMP